Darifenacin provides meaningful improvements to patients dissatisfied with oxybutynin or tolterodine therapy

Newman D1, Koochaki P2, Fix D2

Abstract Category

Neurourology: Clinical

Abstract 454
Non-Discussion Posters
Scientific Non Discussion Poster Session 32
1. University of Pennsylvania, 2. Procter & Gamble Pharmaceuticals
Links

Abstract